Skip to main content

Table 1 The expression of LINC00261and its clinical character in multiple cancers

From: LINC00261: a burgeoning long noncoding RNA related to cancer

Cancer type Property Expression Cases Clinical character Prognosis PMID
Pancreatic cancer Suppressor 229 Prognosis Favorable 30,210,701
   / Prognosis Favorable 32,414,223
   40 Prognosis Favorable 32,929,371
   / Prognosis Favorable 33,122,827
Gastric cancer Suppressor / Prognosis Favorable 27,439,973
   / Prognosis Favorable 27,878,953
 Colon cancer Suppressor 138 Prognosis Favorable 31,850,713
Lung cancer Suppressor 150 Prognosis Favorable 29,272,004
   52 Prognosis Favorable 31,190,356
   78 Prognosis Favorable 32,607,060
   881 Prognosis Favorable 32,181,394
Hepatocellular carcinoma Suppressor 45 Prognosis Favorable 29,278,875
   317 Prognosis Favorable 29,761,859
   44 Prognosis Favorable 33,520,374
   74 Prognosis Favorable 30,377,132
Breast cancer stem cells Suppressor 103 Prognosis Favorable 33,274,565
Laryngeal carcinoma Suppressor 66 Prognosis Favorable 29,774,690
Prostate cancer Suppressor 83 Prognosis Favorable 33,013,201
Choriocarcinoma Suppressor 60 Prognosis Favorable 27,983,929
Cholangiocarcinoma Oncogene 50 Prognosis Poor 31,812,439